SEC Form 4 · accession 0001104659-15-058048
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maurice L Castonguay
Officer — Chief Financial Officer
Period of report
Aug 6, 2015
Accepted (ET)
Aug 10, 2015 · 11:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $14.04 | Aug 6, 2015 | A | 146,000 | A | — | Aug 6, 2025 | Common Stock | 146,000 | 146,000 | D |
Explanation of responses
- F125% of the total shares vest on 08/06/2016, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 08/06/2019.